Safety and Efficacy of a New and Emerging Dental X ray Modality
The aim of this proposal is the acquisition of the key information necessary for sound and scientifically based clinical use of dental Cone Beam Computed Tomography (CBCT). In order that safety and efficacy are assured and enhance...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EPI-CT
Epidemiological study to quantify risks for paediatric compu...
7M€
Cerrado
PEDDOSE.NET
Dosimetry and Health Effects of Diagnostic Applications of R...
603K€
Cerrado
OE Scan
A next generation diagnostic device that effectively screens...
71K€
Cerrado
MADEIRA
Minimizing Activity and Dose with Enhanced Image quality by...
4M€
Cerrado
PHASETOMO
Development of a three dimensional Reconstruction Algorithm...
100K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The aim of this proposal is the acquisition of the key information necessary for sound and scientifically based clinical use of dental Cone Beam Computed Tomography (CBCT). In order that safety and efficacy are assured and enhanced in the ‘real world’, the parallel aim is to use the information to develop evidence-based guidelines dealing with justification, optimisation and referral criteria and to provide a means of dissemination and training for users of CBCT. The objectives and methodology of the proposed collaborative project are: 1. To develop evidence-based guidelines on use of CBCT in dentistry, including referral criteria, quality assurance guidelines and optimisation strategies. Guideline development will use systematic review and established methodology, involving stakeholder input. 2. To determine the level of patient dose in dental CBCT, paying special attention to paediatric dosimetry, and personnel dose. 3. To perform diagnostic accuracy studies for CBCT for key clinical applications in dentistry by use of in vitro and clinical studies. 4. To develop a quality assurance programme, including a tool/tools for quality assurance work (including a marketable quality assurance phantom) and to define exposure protocols for specific clinical applications. 5. To measure cost-effectiveness of important clinical uses of CBCT compared with traditional methods. 6. To conduct valorisation, including dissemination and training, activities via an ‘open access’ website. At all points, stakeholder involvement will be intrinsic to study design.